Literature DB >> 3153508

Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report.

E Kramer-Ginsberg, R C Mohs, M Aryan, D Lobel, J Silverman, M Davidson, K L Davis.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3153508

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  7 in total

Review 1.  Acetylcholinesterase inhibitors in Alzheimer's disease.

Authors:  B M McGleenon; K B Dynan; A P Passmore
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 2.  Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?

Authors:  Ben Seltzer
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

3.  Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.

Authors:  F P Zemlan
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Efficacy of Cilostazol Administration in Alzheimer's Disease Patients with White Matter Lesions: A Positron-Emission Tomography Study.

Authors:  Jun-Young Lee; Haewoo Lee; Hye Bin Yoo; Jung-Seok Choi; Hee-Yeon Jung; Eun Jin Yoon; Hongrae Kim; Ye-Ha Jung; Ho-Young Lee; Yu Kyeong Kim
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

5.  Factors affecting the age of onset and rate of progression of Alzheimer's disease.

Authors:  J V Bowler; D G Munoz; H Merskey; V Hachinski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

6.  Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.

Authors:  Asa K Wallin; Carina Wattmo; Lennart Minthon
Journal:  Neuropsychiatr Dis Treat       Date:  2011-09-30       Impact factor: 2.570

7.  Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.

Authors:  Carina Wattmo; Åsa K Wallin
Journal:  Alzheimers Res Ther       Date:  2017-08-31       Impact factor: 6.982
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.